Literature DB >> 25625299

Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer.

Junmin Song1, Hongxiang Liu1, Zhen Li1, Chao Yang1, Chaojie Wang2.   

Abstract

Colorectal cancers are the third most common types of cancers worldwide. Surgical resection is unable to eliminate tumors completely due to metastasis. A demand for new chemotherapeutic tools exists. In the present study, we examined the chemopreventive potential of cucurbitacin I, a natural component extracted from plants of the Cucurbitaceae family, in the colon cancer cell line COLO205. We hypothesized that cucurbitacin I would prevent colon cancer cell migration and invasion, and sensitize colon cancer cells to chemotherapy. Our data demonstrated that exposure of the COLO205 cells to cucurbitacin I significantly decreased cell viability. Furthermore our data demonstrated for the first time that in the COLO205 cells, cucurbitacin I could suppress the cell migration and invasion, and harbor chemosensitization activity against colon cancer. The anticancer activity of cucurbitacin I was accomplished by downregulating p-STAT3 and MMP-9 expression. Collectively, our results suggest that cucurbitacin I may be a potent adjuvant chemotherapeutic agent for colon cancer with anti-migration, anti-invasion and chemosensitizing activities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25625299     DOI: 10.3892/or.2015.3749

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

Review 1.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 2.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

3.  Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways.

Authors:  Tai Yang; Jin Liu; Mali Yang; Ning Huang; Yueling Zhong; Ting Zeng; Rong Wei; Zhongjun Wu; Cui Xiao; Xiaohua Cao; Minhui Li; Limei Li; Bin Han; Xiaoping Yu; Hua Li; Qiang Zou
Journal:  Oncotarget       Date:  2017-01-24

4.  Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.

Authors:  Bijiao Zhou; Shumin Zong; Weilong Zhong; Yixuan Tian; Lumeng Wang; Qian Zhang; Renya Zhang; Lei Li; Wei Wang; Jianmin Zhao; Xin Chen; Yaju Feng; Binghui Zhai; Tao Sun; Yanrong Liu
Journal:  Oncogene       Date:  2019-11-01       Impact factor: 8.756

5.  AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.

Authors:  Hong Zhu; Lin-Lin Chang; Fang-Jie Yan; Yan Hu; Chen-Ming Zeng; Tian-Yi Zhou; Tao Yuan; Mei-Dan Ying; Ji Cao; Qiao-Jun He; Bo Yang
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.